3rd Strategic Partnerships for Drug Repurposing Forum -

3rd Strategic Partnerships for Drug Repurposing Forum
October 25 - 26, 2018
TBA

Discover the Latest Indications for Repurposing, Rescuing and Repositioning Exciting Drugs to Explore New Innovations

3rd Strategic Partnerships for Drug Repurposing Forum – 3rd Strategic Partnerships for Drug Repurposing Forum

Advisory Board


Bruce Bloom
,
President and Chief Science Officer,
CURES WITHIN REACH

Zhichao Liu,
Staff Fellow, NCTR,
FDA

Aris Persidis,
President,
BIOVISTA

Hassan Al-Ali, Ph.D.,
Research Assistant Professor,
UNIVERSITY OF MIAMI

Chad Nivens,
Director Translational Sciences,
ASTRAZENECA

In today’s society, life science organizations not only develop strategies and methods to help find cures for diseases; they also utilize data from past clinical trials to uncover potential new indications to repurpose, reposition or rescue a drug. Organizations can use these strategies to expand treatment options for patients by finding ways to repurpose existing drugs. With more than 7,000 known diseases worldwide, drug repurposing provides an alternative route for companies to provide treatments to patients faster.

Don’t miss out on ExL’s 3rd Strategic Partnership for Drug Repurposing Forum come learn from all stakeholders in the room, which include life science companies, patient advocacy groups, nonprofits/foundations, and governmental/funding partners. Come network with stakeholders and hear the latest indications for repurposing, rescuing and repositioning existing drugs to explore the newest innovations.

 Top Five Reasons to Attend

  1. Engage in case studies and panel discussions on how to excel in searching for drug repurposing opportunities and uncover new indications for existing drugs
  2. Identify new technologies used for the evaluation of repurposed drugs
  3. Explore how to develop strategic partnerships between the government, universities, patient advocacy groups, foundations, and sponsors
  4. Cover new methods in the pipeline by using innovative strategies to discover new therapeutic uses for existing molecules
  5. Identify new indications of marketed drugs for rare and neglected diseases

Who Should Attend

This conference is designed for representatives from pharmaceutical, biotechnology and medical device organizations; patient organizations; and nonprofit foundations with responsibilities in the following areas:

  • Drug Repurposing
  • Indication Expansion
  • Strategic Partnerships and Alliances
  • Global Commercialization/Strategy
  • Program and Portfolio Development
  • Translational Medicine
  • Strategy and Portfolio Solutions
  • Corporate Strategy
  • Market Access
  • Asset Management
  • Advanced Brand Strategies
  • Research and Development
  • Scientific/Clinical Development
  • Regulatory Affairs
  • Bioinformatics
  • Big Data Analytics
  • Patient Networks

This event is also of interest to professionals involved in:

  • Clinical Operations/Clinical Outsourcing
  • Trauma Therapeutics
  • Drug Delivery/Discovery
  • Product Development
  • Clinical Operations
Startdate: 2018-10-26
End Date 2018-10-27

Description: Coming in Fall 2018, the 3rd Strategic Partnerships for Drug Repurposing Forum will take place on October 26-27, 2018. Click here to check out our Advisory Board!
Performer: ExL Events
Address : 3rd Strategic Partnerships for Drug Repurposing Forum


live chat software